July 26, 2022
Video
Closing out the program, Robert Zeiser, MD, shares what he is looking forward to in the field of graft-vs-host-disease.
July 26, 2022
Video
Adverse events related to chronic graft-vs-host-disease therapies and strategies to manage these adverse effects are considered.
July 26, 2022
Video
Robert Zeiser, MD, touches on additional therapeutic options for steroid-refractory chronic graft-vs-host-disease, such as extracorporeal photopheresis, mycophenolate, everolimus, and more.
July 26, 2022
Video
Therapies for steroid-refractory chronic graft-vs-host disease, ibrutinib, ruxolitinib, and belumosudil, are explored in a comprehensive analysis.
July 26, 2022
Video
A GVHD expert comments on the frontline therapy available for the condition.
July 26, 2022
Video
Selection of prophylaxis regimen is reviewed followed by a discussion of the typical patient presentation of GVHD.